Código 292419 (Harmonized System 2012 by 6 digits)
2024: US$50.2M, Total Trade Exchange
2024: US$9.9M, International Sales
2024: US$40.3M, International Purchases
In 2024, the trade exchange (includes international purchases and sales) of Acyclic Amides, Incl Carbamates, and their Derivatives.; Salts Thereof (Excl. Meprobamate "Inn"), Fruoroacetamido (Iso), Nonocrotofos (Iso), and Phosphamidon (Iso) was US$50.2M.
In 2024, the states with the most international sales in Acyclic Amides, Incl Carbamates, and their Derivatives.; Salts Thereof (Excl. Meprobamate "Inn"), Fruoroacetamido (Iso), Nonocrotofos (Iso), and Phosphamidon (Iso) were Nuevo León (US$3.48M), Estado de México (US$230k), Ciudad de México (US$226k), and Guanajuato (US$77.5k).
The states with the most international purchases in 2024 were Ciudad de México (US$15.3M), Nuevo León (US$5.79M), Estado de México (US$4.84M), Jalisco (US$4.02M), and Querétaro (US$2.27M).
In 2024, the main commercial destinations of Acyclic Amides, Incl Carbamates, and their Derivatives.; Salts Thereof (Excl. Meprobamate "Inn"), Fruoroacetamido (Iso), Nonocrotofos (Iso), and Phosphamidon (Iso) were United States (US$3.65M), Guatemala (US$197k), Hong Kong (US$135k), El Salvador (US$8.38k), and Colombia (US$8.19k).
The main commercial origins of Acyclic Amides, Incl Carbamates, and their Derivatives.; Salts Thereof (Excl. Meprobamate "Inn"), Fruoroacetamido (Iso), Nonocrotofos (Iso), and Phosphamidon (Iso) in 2024 were China (US$11.4M), United States (US$7.8M), Switzerland (US$3.15M), United Kingdom (US$3.14M), and India (US$3.12M).
In the global context, the main exporting countries of Acyclic Amides, Incl Carbamates, and their Derivatives.; Salts Thereof (Excl. Meprobamate "Inn"), Fruoroacetamido (Iso), Nonocrotofos (Iso), and Phosphamidon (Iso) in 2022 were China (US$1B), Germany (US$356M), and India (US$354M). In the same year, the main importing countries of Acyclic Amides, Incl Carbamates, and their Derivatives.; Salts Thereof (Excl. Meprobamate "Inn"), Fruoroacetamido (Iso), Nonocrotofos (Iso), and Phosphamidon (Iso) were United States (US$493M), Germany (US$264M), and France (US$228M).
US$50.2M, Total Trade Exchange (2024)
In 2024, the total trade exchange of Acyclic Amides, Incl Carbamates, and their Derivatives.; Salts Thereof (Excl. Meprobamate "Inn"), Fruoroacetamido (Iso), Nonocrotofos (Iso), and Phosphamidon (Iso) in Mexico (including international purchases and sales) was US$50.2M.
The visualizations show the net balance of Acyclic Amides, Incl Carbamates, and their Derivatives.; Salts Thereof (Excl. Meprobamate "Inn"), Fruoroacetamido (Iso), Nonocrotofos (Iso), and Phosphamidon (Iso) at the level of states and countries. Colors more similar to blue, indicate that the territory presented a higher level of international sales. Colors more similar to red, indicate that the territory presented a higher level of international purchases.
April, 2025
In April 2025, international sales of Acyclic Amides, Incl Carbamates, and their Derivatives.; Salts Thereof (Excl. Meprobamate "Inn"), Fruoroacetamido (Iso), Nonocrotofos (Iso), and Phosphamidon (Iso) were US$1.82M, while international purchases reached US$3.64M. The above results in a trade balance of -US$1.83M.
Nuevo León: US$3.48M, State with the Most International Sales (2024)
United States: US$3.65M, Main commercial destination (2024)
In 2024, the states with the highest international sales in Acyclic Amides, Incl Carbamates, and their Derivatives.; Salts Thereof (Excl. Meprobamate "Inn"), Fruoroacetamido (Iso), Nonocrotofos (Iso), and Phosphamidon (Iso) were Nuevo León (US$3.48M), Estado de México (US$230k), Ciudad de México (US$226k), and Guanajuato (US$77.5k).
In 2024, the countries with the most international purchases from Mexico were United States (US$3.65M), Guatemala (US$197k), Hong Kong (US$135k), El Salvador (US$8.38k), and Colombia (US$8.19k).
Ciudad de México: US$15.3M, State with the Most International Purchases (2024)
China: US$11.4M, Main Commercial Origin (2024)
In 2024, the states with the highest international in Acyclic Amides, Incl Carbamates, and their Derivatives.; Salts Thereof (Excl. Meprobamate "Inn"), Fruoroacetamido (Iso), Nonocrotofos (Iso), and Phosphamidon (Iso) were Ciudad de México (US$15.3M), Nuevo León (US$5.79M), Estado de México (US$4.84M), Jalisco (US$4.02M), and Querétaro (US$2.27M).
The countries with the most international sales to Mexico in 2024 were China (US$11.4M), United States (US$7.8M), Switzerland (US$3.15M), United Kingdom (US$3.14M), and India (US$3.12M).
The RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Acyclic Amides, Incl Carbamates, and their Derivatives.; Salts Thereof (Excl. Meprobamate "Inn"), Fruoroacetamido (Iso), Nonocrotofos (Iso), and Phosphamidon (Iso) and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Acyclic Amides, Incl Carbamates, and their Derivatives.; Salts Thereof (Excl. Meprobamate "Inn"), Fruoroacetamido (Iso), Nonocrotofos (Iso), and Phosphamidon (Iso). On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
The visualizations show the global market for Acyclic Amides, Incl Carbamates, and their Derivatives.; Salts Thereof (Excl. Meprobamate "Inn"), Fruoroacetamido (Iso), Nonocrotofos (Iso), and Phosphamidon (Iso). In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Acyclic Amides, Incl Carbamates, and their Derivatives.; Salts Thereof (Excl. Meprobamate "Inn"), Fruoroacetamido (Iso), Nonocrotofos (Iso), and Phosphamidon (Iso) were China (US$1B), Germany (US$356M), and India (US$354M). In the same year, the main importing countries for Acyclic Amides, Incl Carbamates, and their Derivatives.; Salts Thereof (Excl. Meprobamate "Inn"), Fruoroacetamido (Iso), Nonocrotofos (Iso), and Phosphamidon (Iso) were United States (US$493M), Germany (US$264M), and France (US$228M).